Borey and Sophia are among the first clients in Cambodia to begin long-acting injectable Cabotegravir (CAB-LA), a PrEP ...

Thailand’s HIV crisis is back after health chiefs revealed more than half a million people in the kingdom are living with the ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Winning Founding Managing Editor and Executive Director of Cns (Citizen News Service) and Is a Feminist, Health and Development Justice Advocate.

Cambodia is the first country in the Asia-Pacific region to implement CAB-PrEP as part of a comprehensive HIV prevention strategy that offers multiple options for protection.

Another gamechanger which helped Thailand progress towards ending AIDS is generic manufacturing of lifesaving antiretroviral ...

The FDA recently approved Gilead’s drug, lenacapavir, a powerful HIV prevention drug that only requires two shots a year. The ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

About 2.5 million take PrEP, WHO said. More than 39,000 U.S. residents were diagnosed with HIV in 2023, according to the Centers for Disease Control and Prevention.

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV — a move the company hailed as a major breakthrough in the fight against the sexually ...